Dr. Sun Jong Kim is a highly accomplished biotechnology and life sciences professional whose career reflects sustained contributions to in vitro diagnostics, stem cell science, biomolecular research, and translational biomedical innovation. Equipped with a strong academic foundation including bachelor’s, master’s, and doctoral studies in life sciences, Dr. Sun Jong Kim has developed deep expertise in cellular biology, developmental biology, and molecular mechanisms of pluripotency. His professional journey includes senior research and leadership roles across multiple biomedical organizations, where he has guided R&D programs involving the establishment and maintenance of pluripotent stem cell lines, large-scale microalgae production systems, medical device development, and regulatory preparation for diagnostic technologies. He has contributed to the development of human embryonic stem cell resources, in vitro differentiation platforms, and advanced diagnostic systems applied to areas such as oncology, COVID-19 rapid testing, and point-of-care technologies. His industrial leadership also includes oversight of product development pipelines, quality assurance systems, and multidisciplinary research operations, demonstrating an ability to translate scientific results into usable biomedical solutions that directly support clinical and research infrastructures. His research outputs include numerous scientific publications, national and international presentations, and patents in areas such as stem cell culturing techniques, photobioreactors, and biomaterial-based innovations. The measurable impact of his scholarly contribution is represented by 24 citations by 24 documents, 2 indexed documents, and an h-index of 2, reflecting ongoing engagement and recognition within the scientific community. Dr. Sun Jong Kim’s research interests encompass stem cell biology, human cell culture systems, the regulation of self-renewal and differentiation pathways, bioprocess design, clinical diagnostics, and biotechnology commercialization. His work has been supported by significant research grants and has contributed to advancements in both academic discovery and applied biomedical engineering. In addition to laboratory research, he has played a crucial role in the development, certification, and evaluation of diagnostic medical devices aligned with international regulatory standards and real-world clinical needs. Through his ongoing work at Biofront and other institutions, Dr. Sun Jong Kim continues to drive innovation in science and technology, contributing to advancements that support more accurate diagnostics, greater understanding of biological systems, and the modernization of biomedical tools used in healthcare and life science research.
Profile: Scopus
Featured Publications:
Kim, S. J.,(1999). Isolation of developmentally regulated novel genes based on sequence identity and gene expression patterns. Molecules and Cells, 9, 207–218.
Kim, S. J.,(2001). Ovarian expression of melatonin Mel(1) receptor mRNA during mouse development. Molecular Reproduction and Development, 59, 126–132.
Kim, S. J.,(2003). Isolation and culture of human embryonic stem-like cells from abnormal blastocysts. Korean Journal of Fertility and Sterility, 30, 293–301.
Kim, S. J.,(2003). Establishment and maintenance of human embryonic stem cells on STO, a permanently growing cell line. Biology of Reproduction, 69, 2007–2014.
Kim, S. J.,(2004). Establishment of embryonic germ cells from cultured human primordial germ cells and their differentiation into neuronal cells. Molecules and Cells, 17, 309–315.
Kim, S. J.,(2004). Recent advances in human embryonic stem cell research. Journal of the Korean Medical Association, 918–925.
Kim, S. J.,(2004). Effects of type IV collagen and laminin on the cryopreservation of human embryonic stem cells. Stem Cells, 22, 950–961.
Kim, S. J.,(2004). Available human feeder cells for the maintenance of human embryonic stem cells. Reproduction, 128, 727–735.